← All stories
Markets
Can Ananda (LSE:ANA) Carry London's Cannabinoid Medicine Story On Its Own?
Highlights The company has become the principal quoted cannabinoid medicine developer in Britain after peers delisted or collapsed. Its lead cannabidiol candidate targets chronic inflammatory pain and has been registered on a public clinica…
Covered by 1 outlet
All coverage · 1 article